ARTICLES

Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.

Managing Partner, Harris Kaplan, joins industry experts in FirstWord ExpertViews: The Future Impact of the Inflation Reduction Act on Pharma Drug Pricing

The decisions that shape commercial success are increasingly being made long before launch. As the Inflation Reduction Act continues to influence pricing, access, and reimbursement dynamics, companies must consider how evidence generation, differentiation, and value communication fit into their development strategy from the outset. In FirstWord's ExpertViews report, The Future Impact of the Inflation Reduction Act on Pharma Drug Pricing, Harris Kaplan shares his perspective a

Jun 41 min read

Silhouette of a head with a blue maze pattern, red glow in the center, on a textured gray background, symbolizing complexity or thought.

Managing Partner, Harris Kaplan, published in PM360: Into the Mind of the Payer

Harris Kaplan , Managing Partner, just published an article on PM360, Into the Mind of the Payer . Harris has interviewed countless...

Apr 26, 20211 min read

Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Harris Kaplan , Managing Partner, has partnered with Fred Dotzler to write the cover story for In Vivo January 2019. The article delves into what payers are doing in today’s world to try to control the cost of new life science products, and what steps they plan on taking to better control rising costs in the future. Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Jan 16, 20191 min read

Mail